Blog

Postpartum depression (PPD) is a serious mood disorder that can affect women after childbirth. Unlike the more common and temporary "baby blues," which typically resolve within two weeks, postpartum depression can last much longer and significantly impact a mother’s ability to care for herself and her baby. Learn more.

A patient must receive essential treatment for a brain tumor, even during an evacuation warning for the raging Pacific Palisades fire in 2025.

In recent years, the cancer treatment landscape has begun shifting toward more personalized approaches. This is important because GMB tumors are heterogeneous i.e. no two individuals' tumors are alike. The results of a recent study in which Dr. Santosh Kesari was a collaborator, published in the August 2024 issue of Nature Communications, offer new hope. The study presents compelling evidence for a peptide vaccine that could extend survival for some GBM patients. Learn more.

The third Wednesday of each July is Glioblastoma Awareness Day. Glioblastoma (GBM) is a complex and invasive form of brain cancer, presenting difficulties in its treatment. Learn more about GMB, clinical trials and the Cancer Moonshot.

SANTA MONICA (Dec. 4, 2023) — Promising results of a pilot study at Providence Saint John’s Health Center to treat a rare form of cancer of the spine and skull base were published today by the journal Clinical Cancer Research.

Immersive nature videos may enhance psychedelic-assisted therapy for alcohol addiction, according to research by Pacific Neuroscience Institute and renowned filmmaker Louie Schwartzberg.

Expert neuro-oncologist Santosh Kesari, MD, PhD, Director of Neuro-oncology at Pacific Neuroscience Institute and Chair and Professor of the Department of Translational Neurosciences at Saint John’s Cancer Institute, published the results from a phase 2 clinical trial for recurrent glioblastoma (rGBM), offering hope for improved survival outcomes and pushing novel treatment one step closer to FDA approval.

With nearly two decades of nonprofit management and fundraising experience, Melissa B. Coleman, Esq, Vice President of the PNI Foundation (PNIF), is an expert at building programmatic research teams in support of neurosciences.

At Pacific Neuroscience Institute® (PNI) we achieved many milestones in 2022 and continue to make positive impacts in neuroscience clinical care, research, and education.

Renowned neuro-oncologist Santosh Kesari, MD, PhD, is one of the authors of a phase 3 trial that found that the use of an autologous tumor lysate-loaded dendritic cell vaccine (DCVax-L) added to the standard of care (SOC) treatment of both newly diagnosed glioblastoma and recurrent glioblastoma...